Patents by Inventor Bradley Sherborne

Bradley Sherborne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GCN2 MODULATING COMPOUNDS AND USES THEREOF
    Publication number: 20240150345
    Abstract: Provided herein are compounds, compositions, and methods useful for modulating the activity of GCN2 and for treating related conditions, diseases, and disorders (e.g., cancer and neurodegenerative diseases).
    Type: Application
    Filed: January 21, 2022
    Publication date: May 9, 2024
    Inventors: Savithri Ramurthy, Mark J. Mulvihill, Bradley Sherborne, Benjamin Rahemtulla, Eric P.A. Talbot, Christopher G. Thomson
  • GCN2 MODULATING COMPOUNDS AND USES THEREOF
    Publication number: 20240083897
    Abstract: Provided herein are compounds, compositions, and methods useful for modulating the activity of GCN2 and for treating related conditions, diseases, and disorders (e.g., cancer and neurodegenerative diseases).
    Type: Application
    Filed: January 21, 2022
    Publication date: March 14, 2024
    Inventors: Savithiri Ramurthy, Mark J. Mulvihill, Bradley Sherborne, Benjamin Rahemtulla, Eric P.A. Talbot, Christopher G. Thomson
  • (AZA)INDAZOLYL-ARYL SULFONAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
    Publication number: 20220388964
    Abstract: The invention provides (aza)indazolyl-aryl sulfonamide and related compounds, pharmaceutical compositions, and their use in the treatment of medical conditions, such as cancer, and in inhibiting GCN2 activity.
    Type: Application
    Filed: April 13, 2020
    Publication date: December 8, 2022
    Inventors: Savithri Ramurthy, Mark J. Mulvihill, Bradley Sherborne, Eric Talbot, Chris Thomson, Thomas Daniel Aicher, Fernando Padilla, Clarke B. Taylor, Peter L. Toogood